AstraZeneca aims for a full listing in New York, but remains headquartered in the United Kingdom.
Adrian Rusu
International
Foto: shutterstock.com/ro
Always see our news on Google
AstraZeneca announced on Monday that it intends to move to a direct listing of its shares on the New York Stock Exchange, in a move aimed at capitalizing on the high appetite of American investors, but emphasized that it will not leave London.
Sources
Gigantul farmaceutic european AstraZeneca vizează listare completă la New York
AstraZeneca vizează listare completă la New York, dar îşi reafirmă angajamentul faţă de Londra
UK plc can't afford to lose AstraZeneca to Wall Street
AstraZeneca's listing rejig spells long-term danger for London | Nils Pratley
AstraZeneca trece la listare directă pe bursa din New York, dar rămâne cu sediul în Marea Britanie
Latest News
17:17
The government has extended the special measures for Transelectrica until September 30, including the reduction of energy exports, in the context of the hydrological deficit and increasing consumption.
17:03
Over 113,000 Russians have crossed the border into Georgia amid rumors of a new military mobilization.
17:03
Nepal refuses international aid for search and rescue operations after the devastating floods
16:49
Online fraud alerts in Romania / Hackers use various methods, including voice cloning, to deceive people
16:35
Plane too heavy for takeoff. Passengers on a flight to Naples were left without luggage.
See more news
NEWS ON THE SAME TOPICS
International
AstraZeneca, negotiations with Bristol Myers Squibb for a possible merger that could create a 400 billion dollar group
International
AstraZeneca announced the failure of a drug for a rare heart condition, causing a 9% drop in the company's shares.
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
.webp)
